Scynexis (SCYX) Tax Provisions (2014 - 2024)
Scynexis (SCYX) posted Tax Provisions of $72000.0 for Q4 2024, up 118.23% on a QoQ basis from -$395000.0 in Q3 2024, and down 96.08% year-over-year from $1.8 million in Q1 2024.
Scynexis (SCYX) Tax Provisions (2014 - 2024) Analysis & Trends
Scynexis' Tax Provisions history runs 7 years deep, the most recent figure standing at $72000.0 for Q4 2024.
- Quarterly Tax Provisions fell 96.08% year-over-year to $72000.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $72000.0 (down 96.35% YoY) and the FY2024 annual result came in at $200000.0, down 89.12% from the prior year.
- Tax Provisions was $72000.0 for Q4 2024 at Scynexis, up from -$395000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $5.1 million in Q4 2022 and bottomed at -$9.1 million in Q4 2020.
- A 5-year average of -$1.1 million and a median of -$31000.0 in 2021 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2020 — Tax Provisions plunged 906.19% — and 2022, when it surged 42425.0%.
- Scynexis' Tax Provisions stood at -$9.1 million in 2020, then jumped by 99.87% to -$12000.0 in 2021, then jumped by 42425.0% to $5.1 million in 2022, then tumbled by 63.79% to $1.8 million in 2023, then plunged by 96.08% to $72000.0 in 2024.
- Business Quant data shows SCYX's Tax Provisions at $72000.0 in Q4 2024, -$395000.0 in Q3 2024, and $531000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 72,000.00 |
| Sep 30, 2024 | -395,000.00 |
| Mar 31, 2024 | 531,000.00 |
| Dec 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 5.08 Mn |
| Mar 31, 2022 | -4.70 Mn |
| Dec 31, 2021 | -12,000.00 |
| Sep 30, 2021 | -50,000.00 |
| Jun 30, 2021 | -4.14 Mn |
| Mar 31, 2021 | 1.10 Mn |
| Dec 31, 2020 | -9.11 Mn |
| Jun 30, 2020 | -3.14 Mn |
| Dec 31, 2019 | -905,000.00 |
| Dec 31, 2014 | -257,000.00 |
| Sep 30, 2014 | -338,000.00 |